Prosight Management as of Sept. 30, 2022
Portfolio Holdings for Prosight Management
Prosight Management holds 38 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 10.4 | $20M | 321k | 60.63 | |
| Horizon Therapeutics Pub L SHS | 10.0 | $19M | 303k | 61.89 | |
| Galapagos Nv Spon Adr (GLPG) | 9.3 | $17M | 405k | 42.64 | |
| Kezar Life Sciences | 6.1 | $11M | 1.3M | 8.61 | |
| Alkermes SHS (ALKS) | 6.0 | $11M | 502k | 22.33 | |
| Albireo Pharma | 5.1 | $9.5M | 491k | 19.36 | |
| Meiragtx Holdings (MGTX) | 5.0 | $9.3M | 1.1M | 8.41 | |
| Kalvista Pharmaceuticals (KALV) | 4.1 | $7.7M | 530k | 14.51 | |
| Charles River Laboratories (CRL) | 3.5 | $6.5M | 33k | 196.81 | |
| Aldeyra Therapeutics (ALDX) | 3.5 | $6.5M | 1.2M | 5.34 | |
| Humana (HUM) | 3.3 | $6.2M | 13k | 485.16 | |
| Mirum Pharmaceuticals (MIRM) | 3.2 | $6.0M | 285k | 21.01 | |
| Tenet Healthcare Corp Com New (THC) | 2.8 | $5.3M | 102k | 51.58 | |
| Johnson & Johnson (JNJ) | 2.8 | $5.2M | 32k | 163.35 | |
| Quidel Corp (QDEL) | 2.4 | $4.5M | 63k | 71.48 | |
| Cue Biopharma (CUE) | 1.8 | $3.4M | 1.5M | 2.23 | |
| Prothena Corp Call Call Option | 1.7 | $3.2M | 53k | 60.62 | |
| Rocket Pharmaceuticals (RCKT) | 1.7 | $3.2M | 200k | 15.96 | |
| Shattuck Labs (STTK) | 1.6 | $3.0M | 1.1M | 2.70 | |
| Oric Pharmaceuticals (ORIC) | 1.6 | $3.0M | 936k | 3.20 | |
| Incyte Corporation (INCY) | 1.4 | $2.7M | 41k | 66.65 | |
| Omnicell (OMCL) | 1.4 | $2.7M | 31k | 87.04 | |
| Avantor (AVTR) | 1.3 | $2.4M | 123k | 19.60 | |
| Baxter International (BAX) | 1.1 | $2.1M | 39k | 53.87 | |
| Rhythm Pharmaceuticals (RYTM) | 1.1 | $2.0M | 80k | 24.50 | |
| 1life Healthcare | 1.0 | $1.8M | 106k | 17.15 | |
| Cassava Sciences Put Put Option | 0.8 | $1.5M | 36k | 41.81 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $1.4M | 114k | 12.60 | |
| Ardelyx (ARDX) | 0.7 | $1.3M | 1.1M | 1.19 | |
| Evolus (EOLS) | 0.7 | $1.3M | 160k | 8.05 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.7 | $1.3M | 1.7M | 0.74 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.6 | $1.2M | 248k | 4.82 | |
| Graphite Bio | 0.6 | $1.1M | 356k | 3.17 | |
| Silverback Therapeutics (SPRY) | 0.6 | $1.0M | 196k | 5.28 | |
| Abcellera Biologics (ABCL) | 0.5 | $856k | 87k | 9.90 | |
| R1 RCM (RCM) | 0.3 | $595k | 32k | 18.53 | |
| Spok Holdings (SPOK) | 0.3 | $497k | 65k | 7.65 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $218k | 8.5k | 25.53 |
